Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Journey Medical Corp changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 17 | 20 | +3 |
| Shares | 1.69M | 1.65M | −40.9K (−2.4%) |
| Value | $2.62M | $2.63M | +$7.22K (+0.3%) |
New holders (5)
Institutions that held Journey Medical Corp at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Brighton Jones LLC | 23,020 | $36.6K | 0.00% |
| Two Sigma Securities, LLC | 12,016 | $19.1K | 0.00% |
| Renaissance Technologies LLC | 11,500 | $18.0K | 0.00% |
| BerganKDV Wealth Management, LLC | 2,000 | $3.18K | 0.00% |
| Royal Bank of Canada | 78 | $0 | 0.00% |
Sold out (2)
Institutions that held Journey Medical Corp at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Wealth Alliance Advisory Group, LLC | 10,748 | $16.9K |
| Cerity Partners LLC | 25,421 | – |